Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

Nicola G. Ghazi, Emad B. Abboud, Sawsan R. Nowilaty, Hisham Alkuraya, Abdulrahman Alhommadi, Huimin Cai, Rui Hou, Wen‐Tao Deng, Sanford L. Boye, Abdulrahman M. Almaghamsi, Fahad Al Saikhan, Hassan A. Al-Dhibi, David G. Birch, Christopher Chung, Dilek Çolak, Matthew M. LaVail, Douglas Vollrath, Kirsten E. Erger, Wen‐qiu Wang, Thomas J. Conlon, Kang Zhang, William W. Hauswirth, Fowzan Sami Alkuraya

View at source ↗Article243 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1007/s00439-016-1637-y
Published
Jan 29, 2016
Venue
Human Genetics
DOI
10.1007/s00439-016-1637-y
PubMed
26825853
Categories
Retinal Development and Disorders
Provenance
openalex

Topics